KNect365 Life Sciences is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Oligo, Peptide, mRNA and CRISPR Therapeutics Survey 2019 - tell us your views

TIDES Survey 2019 It is an exciting time in the oligo, peptide, mRNA and CRISPR therapeutics industry with massive potential opportunities and challenges around drug development, manufacture, delivery, technologies, regulations and collaborations. We are conducting a survey across industry professionals from pharma and biotechs, service providers, CDMOs, academia and regulators around the world. The final report will reveal unique insights into how insiders really view the state of the oligo, peptide, mRNA and CRISPR therapeutics industry. Complete the State of the Industry 2019 survey here

Complete the survey to win a 2-day conference pass

Completing the survey will only take a few minutes and will give you exclusive early access to the final report. All answers will remain anonymous and everyone who completes the survey by Sunday May 19, 2019 will be entered into a prize draw for a free 2-day conference pass to their choice of KNect365 Life Sciences TIDES conferences (full terms and conditions can be found here):

- TIDES Europe: 12-15 Nov 2019, Amsterdam, The Netherlands
- AsiaTIDES: 24-26 Feb 2020, Kyoto, Japan
- TIDES US: 11-14 May 2020, Boston, MA

We’re excited to see the results of this study and we hope you are too.

Complete the State of the Industry 2019 survey here

Get articles like this by email